← Back
$HCA All transactions

HCA Healthcare, Inc.

J

$ Value

Shares

36,557,141

Price

Filed

Feb 10

Insider

Name

Frist William R

Title

CIK

0001433377

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-02-06

Code

J

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

36,557,141

Footnotes

On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended. | Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 3,156,495 Shares by the Reporting Person; and 8,713,110 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee. | This number includes restricted share units payable in 12,875 Shares, which will be delivered to the Reporting Person on the date he ceases to be a director of the Issuer. | Hercules Holding II ("Hercules") holds 32,282,889 Shares. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Hercules, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Hercules partnership units to the extent of: 941,766 Shares by the Reporting Person; 9,021 Shares by the Reporting Person's spouse and children; 12,287,166 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee; and 1,147,830 Shares by family partnerships or vehicles of which the Reporting Person is an officer or managing member. | These Shares are held by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee. | These Shares are held by family partnerships or vehicles of which the Reporting Person is an officer or managing member.

Filing Info

Accession No.

0001140361-26-004685

Form Type

4

Issuer CIK

0000860730

Frist William R's History

Date Ticker Type Value
2026-02-06 HCA J
2026-02-06 HCA J
2025-04-30 HCA J $3.6M
2025-04-29 HCA A $0

Other Insiders at HCA (90d)

Insider Bought Sold Last
FRIST THOMAS F JR 2026-02-06
HAZEN SAMUEL N
CEO
$21.5M 2026-02-10
FRIST THOMAS F III 2026-02-06
HERCULES HOLDING II 2026-02-06
Frisco Holding II 2026-02-06
Elcan Patricia F 2026-02-06
Frist William R 2026-02-06
Foster Jon M
EVP and COO
2026-02-10
Cuffe Michael S.
EVP and Chief Clinical Officer
$747K 2026-02-10
Wyatt Christopher F.
SVP & Controller
$2.0M 2026-02-11
Berres Jennifer
SVP & Chief Human Res. Officer
$4.1M 2026-02-11
McAlevey Michael R
EVP & Chief Legal & Admin Off.
$904K 2026-02-18
Marks Mike A
EVP and CFO
2026-02-10
Rossitto Erica
SVP & Chief Nurse Executive
2026-02-10